Trial Profile
Understanding Typhoid Disease After Vaccination: a Single Centre, Randomised, Doubleblind, Placebo Controlled Study to Evaluate M01ZH09 in a Healthy Adult Challenge Model, Using Ty21a Vaccine as a Positive Control
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 May 2023
Price :
$35
*
At a glance
- Drugs Typhoid vaccine (Primary) ; Typhoid-vaccine-Ty21a
- Indications Typhoid
- Focus Therapeutic Use
- 03 May 2023 Status changed from active, no longer recruiting to completed.
- 07 Dec 2020 Planned End Date changed from 31 Aug 2019 to 31 Aug 2021.
- 17 Oct 2018 Planned End Date changed from 1 Dec 2018 to 31 Aug 2019.